Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutical Formulations, Inc. (PFI) was a prominent contract manufacturer and private-label supplier of over-the-counter (OTC) pharmaceutical products. The company specialized in the development and large-scale production of solid dosage forms, including tablets, caplets, and capsules, for major retail chains and pharmaceutical brands. Headquartered in Edison, New Jersey, PFI operated extensive manufacturing facilities and provided formulation development services to its clients. The company was a subsidiary of ICC Industries and was publicly traded under the symbol PHFI. Following a period of financial distress, PFI filed for Chapter 11 bankruptcy in 2008, and its primary assets were subsequently acquired by Perrigo Company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutical Formulations.